Literature for vialinin A (C19.001, C48.002 inhibitor)

(Topics flags: T Target, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2016
1. Yoshioka,Y., Namiki,D., Makiuchi,M., Sugaya,K., Onose,J., Ashida,H. and Abe,N.
   Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-alpha production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity
   Bioorg Med Chem Lett26, 4237-4240. PubMed  Europe PubMed DOI  I
2015
2. Yang,J., Xu,P., Han,L., Guo,Z., Wang,X., Chen,Z., Nie,J., Yin,S., Piccioni,M., Tsun,A., Lv,L., Ge,S. and Li,B.
   Cutting edge: ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORgammat
   J Immunol194, 4094-4097. PubMed  Europe PubMed DOI  T  I
2013
3. Yoshioka,Y., Ye,Y.Q., Okada,K., Taniguchi,K., Yoshida,A., Sugaya,K., Onose,J., Koshino,H., Takahashi,S., Yajima,A., Yajima,S. and Abe,N.
   Ubiquitin-specific peptidase 5, a target molecule of vialinin A, is a key molecule of TNF-alpha production in RBL-2H3 cells
   PLoS ONE8, e80931-e80931. PubMed  Europe PubMed DOI  I